Companies: 10,795·Total market cap: $144.5T

Adagene Inc.

Adagene Inc.

ADAGNASDAQHealthcare● Active

$3.26

$-0.06(-1.81%)

Market Cap$122734429

P/E Ratio—

52W High$4.75

52W Low$1.3

Avg Volume252K

Open$3.36

Beta0.59

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Adagene Inc.（ADAG）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ADAG · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.42Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$7.8MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding37.8MShares outstanding history

Next EarningsSep 2, 2026Est.Earnings history

探索 Adagene Inc. 数据

分析师预测$5 · Buy

股息不分红

营收$7.7M+7332.76%

盈利EPS $-0.46+51.58%

财务快照

FY 2025Revenue$7.7M▲ +7332.76% YoY

202320242025

FY 2025Net Income-$17.6M▲ +47.32% YoY

202320242025

FY 2025EPS$-0.46▲ +51.58% YoY

202320242025

TTM:Revenue: $7.8MNet Income: -$51.1MEPS: $-1.42View income statement →

分析师评级与目标价

Buy5 位分析师

Strong Buy

0

Buy

5

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$5.00Low

$3.26Current

$5.00Avg Target上涨空间 53.37%

$5.00High

合计: 5 · 买入占比: 100.0%

根据过去 3 个月内 5 位华尔街分析师，ADAG 共识评级为 Buy，12 个月平均目标价 $5.00 （较现价 $3.26 上涨空间 53.37%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$3.26-1.81%$122.7M #2

Adicet Bio, Inc.

$7.22-0.55%$67.5M #3

$2.91-1.02%$26.9M #4

Fortress Biotech, Inc.

$2.85+7.55%$94.7M #5

Gain Therapeutics, Inc.

$1.69-0.59%$72.1M #6

Lite Strategy, Inc.

$0.75+0.81%$25.7M

股票表现

1D-1.81%

1W-3.55%

1M-11.65%

3M+14.79%

YTD+72.49%

1Y+70.68%

5Y-76.17%

关于 Adagene Inc.

CEOPeter Luo

IPO DateFeb 9, 2021

Employees138

CountryCN

Websiteadagene.com

Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineere…

Biotechnology HealthcareNASDAQADRCN

关于股票概览与关键数据

Adagene Inc.（ADAG）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 9, 2021 在 NASDAQ 上市。截至最近交易日，ADAG 股价为 $3.26，市值约为 $122.7M。过去12个月累计回报 +70.68%，年初至今回报 +72.49%。

根据 5 位华尔街分析师，Adagene Inc. 股票共识评级为Buy，12个月平均目标价为 $5.00。2025 财年 Adagene Inc. 营收 $7.7M，净利润 -$17.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Adagene Inc.（ADAG）股价为 $3.26，在 NASDAQ 上市，52周区间为 $1.30 – $4.75。

ADAG 最新股价ADAG quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议